Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Baoding Taifu Pharmaceutical is a specialized pharmaceutical manufacturer based in China and a key subsidiary of China Grand Pharmaceutical and Healthcare Holdings. The company is recognized as one of the world's largest production bases for adrenaline series products, including epinephrine, norepinephrine, and isoprenaline. Its facilities are GMP-certified, enabling the company to supply high-quality active pharmaceutical ingredients (APIs) and finished dosage forms to global markets. Baoding Taifu focuses primarily on emergency medicine, cardiovascular health, and respiratory treatments. As a core manufacturing arm of its parent company, it plays a vital role in the global supply chain for life-saving adrenergic agonists.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Baoding Taifu Pharmaceutical.